75 related articles for article (PubMed ID: 7644656)
1. Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids.
Nakahara H; Noguchi S; Murakami N; Morita M; Tamaru M; Ohnishi T; Hoshi H; Jinnouchi S; Nagamachi S; Futami S
Radiology; 1995 Sep; 196(3):857-62. PubMed ID: 7644656
[TBL] [Abstract][Full Text] [Related]
2. Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements.
Ohnishi T; Noguchi S; Murakami N; Tajiri J; Harao M; Kawamoto H; Hoshi H; Jinnouchi S; Futami S; Nagamachi S
Radiology; 1994 Mar; 190(3):857-62. PubMed ID: 8115640
[TBL] [Abstract][Full Text] [Related]
3. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
Pauleit D; Schüller H; Textor J; Leutner C; Keller E; Sommer T; Träber F; Block W; Boldt I; Schild H
Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
[TBL] [Abstract][Full Text] [Related]
4. Graves ophthalmopathy: role of MR imaging in radiation therapy.
Just M; Kahaly G; Higer HP; Rösler HP; Kutzner J; Beyer J; Thelen M
Radiology; 1991 Apr; 179(1):187-90. PubMed ID: 2006276
[TBL] [Abstract][Full Text] [Related]
5. Protracted hypofractionated radiotherapy for Graves' ophthalmopathy: a pilot study of clinical and radiologic response.
Cardoso CC; Giordani AJ; Wolosker AM; Souhami L; Manso PG; Dias RS; Segreto HR; Segreto RA
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1285-91. PubMed ID: 21550180
[TBL] [Abstract][Full Text] [Related]
6. Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy.
Hiromatsu Y; Tanaka K; Sato M; Kuroki T; Nonaka K; Kojima K; Nishimura H; Nishida H; Kaise N
Endocr J; 1993 Feb; 40(1):63-72. PubMed ID: 7951498
[TBL] [Abstract][Full Text] [Related]
7. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
Hou K; Ai T; Hu WK; Luo B; Wu YP; Liu R
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):938-942. PubMed ID: 29270757
[TBL] [Abstract][Full Text] [Related]
8. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.
Bartalena L; Marcocci C; Chiovato L; Laddaga M; Lepri G; Andreani D; Cavallacci G; Baschieri L; Pinchera A
J Clin Endocrinol Metab; 1983 Jun; 56(6):1139-44. PubMed ID: 6341388
[TBL] [Abstract][Full Text] [Related]
9. Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy.
Pinchera A; Marcocci C; Bartalena L; Panicucci M; Marconcini C; Lepri A; Cavallacci G; Cartei F; Laddaga M
Horm Res; 1987; 26(1-4):177-83. PubMed ID: 3596466
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging in diagnosis and follow-up of minimal thyroid ophthalmopathy.
Matsuo H; Motomura M; Takeo G; Yoshimura T; Tsujihata M; Nagataki S
Jpn J Med; 1991; 30(3):229-32. PubMed ID: 1920963
[TBL] [Abstract][Full Text] [Related]
12. Therapy of Graves' ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation.
Koshiyama H; Koh T; Fujiwara K; Hayakawa K; Shimbo S; Misaki T
Thyroid; 1994; 4(4):409-13. PubMed ID: 7711503
[TBL] [Abstract][Full Text] [Related]
13. Graves ophthalmopathy: MR imaging of the orbits.
Hosten N; Sander B; Cordes M; Schubert CJ; Schörner W; Felix R
Radiology; 1989 Sep; 172(3):759-62. PubMed ID: 2772184
[TBL] [Abstract][Full Text] [Related]
14. Response to tocilizumab treatment in Graves' ophthalmopathy by measuring rectus muscle thickness and chemosis using optical coherence tomography.
de-Pablo-Gómez-de-Liaño L; Fernández-Vigo JI; Troyano-Rivas J; Niño-Rueda C; Romo-López Á; Gómez-de-Liaño R
Arch Soc Esp Oftalmol (Engl Ed); 2018 Aug; 93(8):386-391. PubMed ID: 29937157
[TBL] [Abstract][Full Text] [Related]
15. Ocular myasthenia gravis associated with euthyroid ophthalmopathy.
Kusuhara T; Nakajima M; Imamura A
Muscle Nerve; 2003 Dec; 28(6):764-6. PubMed ID: 14639594
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of radiation therapy in the treatment of Graves' orbitopathy.
Matthiesen C; Thompson JS; Thompson D; Farris B; Wilkes B; Ahmad S; Herman T; Bogardus C
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):117-23. PubMed ID: 21030157
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of orbital irradiation combined with or without systemic high-dose or pulsed corticosteroids for Graves' ophthalmopathy.
Tsujino K; Hirota S; Hagiwara M; Fukada S; Takada Y; Hishikawa Y; Kono M; Abe M
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):857-64. PubMed ID: 11020584
[TBL] [Abstract][Full Text] [Related]
18. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.
Utech CI; Khatibnia U; Winter PF; Wulle KG
Thyroid; 1995 Jun; 5(3):185-93. PubMed ID: 7580266
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity.
Jiang H; Wang Z; Xian J; Li J; Chen Q; Ai L
Acta Radiol; 2012 Feb; 53(1):87-94. PubMed ID: 22184678
[TBL] [Abstract][Full Text] [Related]
20. Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy.
Hiromatsu Y; Kojima K; Ishisaka N; Tanaka K; Sato M; Nonaka K; Nishimura H; Nishida H
Thyroid; 1992; 2(4):299-305. PubMed ID: 1493371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
